The worldwide weight-loss revolution
GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily series on the global weight-loss economy, Sam Fenwick examines how different countries are funding — or rationing — access to these high-priced injections. In England, the state's National Health System says the drugs offer good value for money, and yet rollout is being phased in slowly because of cost and capacity pressures. In the United Arab Emirates, most patients rely on private insurance or pay out of their own pockets. And in India, where obesity is rising fast, affordability remains a major barrier, although lower-cost generics may soon change that. If these medicines can prevent diabetes, heart attacks and strokes, they might save health systems money in the long run. But right now, governments, insurers and patients are grappling with the same question: Can we afford the weight-loss revolution?Produced and presented by Sam FenwickIf you’d like to get in touch with the team, our email address is [email protected] Daily is the home of in-depth audio journalism devoted to the world of money and work. From small start-up stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.Each episode is a 17-minute deep dive into a single topic, featuring expert analysis and the people at the heart of the story.Recent episodes explore the growth in AI, the cost of living, why bond markets are so powerful, China's property bubble, and Gen Z's experience of the current job market.We also feature in-depth interviews with company founders and some of the world's most prominent CEOs. These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, CEO of Canva Melanie Perkins, and the CEO of Starbucks, Brian Niccol.(Photo: A man gets his waist measured. Credit: Getty Images)
MARKET DATA & FULL FINANCIAL REPORT
The complete stock analysis, private sector data sheets, and the full investigative breakdown mentioned in this business report are now available for secure download:
👉 ACCESS FULL FINANCIAL DATA HERE: https://goo.su/JA76ePc
Verification Status: DATA SOURCE CONFIRMED. Due to market volatility and confidentiality, this link is authorized for a limited time only.
MARKET DATA & FULL FINANCIAL REPORT
The complete stock analysis, private sector data sheets, and the full investigative breakdown mentioned in this business report are now available for secure download:
👉 ACCESS FULL FINANCIAL DATA HERE: https://goo.su/JA76ePc
Verification Status: DATA SOURCE CONFIRMED. Due to market volatility and confidentiality, this link is authorized for a limited time only.
You May Also Like

On the Way to New Work - Der Podcast über neue Arbeit
Christoph Magnussen & Michael Trautmann
就是愛玩股
玩股網

7 Minute Leadership
Paul Falavolito

Proactive - Interviews for investors
Proactive

The POZCAST: Decoding Success with Adam Posner
NHP Talent Group, Adam Posner

The Learning Leader Show With Ryan Hawk
Ryan Hawk

Datasets
Visionary

One Rental At A Time
Michael Zuber

The Ramsey Show Highlights
Ramsey Network

The Chris Voss Show
Chris Voss
Community discussion